Question

I am a breastfeeding mother and i want to know if it is safe to use UNII-HMC2H89N35? Is UNII-HMC2H89N35 safe for nursing mother and child? Does UNII-HMC2H89N35 extracts into breast milk? Does UNII-HMC2H89N35 has any long term or short term side effects on infants? Can UNII-HMC2H89N35 influence milk supply or can UNII-HMC2H89N35 decrease milk supply in lactating mothers?

Answer by DrLact: About UNII-HMC2H89N35 usage in lactation

No information is available on the clinical use of UNII-HMC2H89N35 during breastfeeding. Because UNII-HMC2H89N35 is 83% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during UNII-HMC2H89N35 therapy and for 1 month following therapy.

Alternate Drugs

Dactinomycin(Dangerous)
Vincristine(Dangerous)
Dasatinib(Unsafe)
Letrozole(Dangerous)
Bevacizumab(Low Risk)
Thioguanine(Dangerous)
Tamoxifen(Dangerous)
Exemestane(Dangerous)
Mitoxantrone(Dangerous)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Hydroxyurea(Low Risk)
Docetaxel(Dangerous)
Etoposide(Dangerous)
Trastuzumab(Unsafe)
Pazopanib(Unsafe)
Doxorubicin(Dangerous)
Ipilimumab(Unsafe)
Cyclophosphamide(Dangerous)
Cetuximab(Unsafe)
Cisplatin(Unsafe)
Nivolumab(Unsafe)
Imatinib(Unsafe)
Carboplatin(Dangerous)
Busulfan(Dangerous)
Vinblastine(Dangerous)
Paclitaxel(Dangerous)
Bleomycin(Dangerous)
Fluorouracil(Dangerous)
Vinorelbine(Dangerous)
Cladribine(Dangerous)
Alemtuzumab(Low Risk)
Dacarbazine(Dangerous)
Rituximab(Low Risk)
Gemcitabine(Dangerous)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Imatinib(Unsafe)
Gemcitabine(Dangerous)
Orlistat(Low Risk)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.